Showing Results for: “diabetes”

The American Diabetes Association ® (ADA) applauds the Commonwealth of Virginia and Governor Abigail Spanberger for signing House Bill 1214 into law, enhancing the state’s existing insulin affordability protections and adding cost-sharing limits to diabetes-related equipment and supplies, becoming the sixth state to do so, an important step to further lower costs for Virginians who rely on insulin and diabetes supplies. Diabetes equipment and supplies are integral to proper diabetes care. HB1214 places limits on cost-sharing payments for insulin and related diabetes equipment and supplies

The American Diabetes Association® (ADA) issued the following statement in response to the House Appropriations Committee’s passage of the Fiscal Year (FY) 2027 funding bill for the Department of Health and Human Services (HHS). This week, the House Appropriations Committee passed a FY 2027 funding measure that provides incremental funding increases for diabetes research and prevention programs at the National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC). Diabetes is one of the most expensive chronic diseases and is the seventh leading cause of death in the U

“The American Diabetes Association ® (ADA) is the leading voice advocating for insulin affordability and is working to ensure that all people with diabetes have access to the care they need. The ADA has led the charge to enact cost-sharing limits on insulin in 22 states and D.C., and the first-ever federal copay cap in Medicare. We are encouraged that all of the major manufacturers have taken steps to make insulin more affordable, but the fight is not over. We will continue advocating for efforts in Congress and states across the country to ensure insulin is affordable to everyone with

Insulin Price Reduction Act, Safe Step Act, and Chronic Condition Copay Elimination Act are first bills analyzed and supported by ADA’s newly launched Advocacy Engagement Platform The American Diabetes Association (ADA) announced formal endorsement of three bills aiming to reduce the high cost of insulin and prescription drugs: the Insulin Price Reduction Act, the Safe Step Act, and the Chronic Condition Copay Elimination Act. The three bills were analyzed using ADA’s newly launched Engagement Platform. The Insulin Price Reduction Act (H.R.4906/S.2199) will reduce the skyrocketing cost of

American Heart Association ® and American Diabetes Association ® reveal results of Know Diabetes by Heart ™ survey and share practical tips for staying on track with health goals through the holiday season Nearly half (49%) of people living with type 2 diabetes said managing their condition during a typical fall and winter holiday season is more difficult than other times of the year, according to a new survey for the American Heart Association and American Diabetes Association. The online survey of more than 1,000 U.S. adults 45 and older completed by real-time market research platform

The American Diabetes Association ® applauds the New York governor and legislature for passing insulin co-pay cap in state budget Recently, New York State Senate Bill 7506-B (S7506B) was signed into law by Governor Andrew Cuomo as part of the 2020 New York State Budget. A provision in the law limits cost sharing for insulin to $100 per 30-day supply for those with state-regulated commercial insurance, a measure supported by the American Diabetes Association (ADA). The new law will take effect as plans are issued or renewed in the upcoming year. LaShawn McIver, MD, MPH, Senior Vice President of

Findings Indicate Improvements in Mental and Physical Health as well as a Reduction in Healthcare Costs For People Living with Type 1 Diabetes Results from two studies evaluating the impact of mental health support for diabetes patients found significant benefits in patient outcomes were presented today at the 83rd Scientific Sessions of the American Diabetes Association ® (ADA) in San Diego, CA. As the number of diabetes cases continues to rise, addressing mental health challenges is a critical element in helping individuals with diabetes manage their care plan. Diabetes distress (DD) for

The American Diabetes Association ® applauds the West Virginia governor and legislature for passing HB 4543 Recently, House Bill 4543 (HB 4543) was signed into law by West Virginia Governor Jim Justice. This legislation, which was supported by the American Diabetes Association (ADA), will limit cost sharing to $100 per 30-day supply of insulin for those with state-regulated commercial insurance. The new law also provides coverage for diabetes self-management education (DSME) and provides a new coverage mandate for blood glucose monitors, monitor supplies, insulin, injection aids, syringes

The American Diabetes Association ® applauds the Virginia governor and legislature for passing HB 66 Recently, House Bill 66 (HB 66) was signed into law by Virginia Governor Ralph Northam. This legislation, which was supported by the American Diabetes Association (ADA), will limit cost sharing to $50 per 30-day supply of insulin for those with state-regulated commercial insurance. LaShawn McIver, MD, MPH, Senior Vice President of Government Affairs & Advocacy for the ADA, issued the following statement: “Insulin has tripled in price between 2002 and 2013, forcing far too many Americans to make

The American Diabetes Association ® (ADA) is proud to announce that its strong financial health and ongoing accountability and transparency have earned it a Four-Star Rating from Charity Navigator. This rating designates the ADA as an official “Give with Confidence” charity, indicating that the ADA is using its donations effectively based on Charity Navigator’s criteria. Charity Navigator is America’s largest and most utilized independent charity evaluator. Since 2001, the organization has been an unbiased and trusted source of information for more than 11 million donors annually. Charity